Your browser doesn't support javascript.
loading
Therapeutic effect of hemin on gestational hypertension in rats and the mechanism / 南方医科大学学报
Article em Zh | WPRIM | ID: wpr-355323
Biblioteca responsável: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To investigate the therapeutic effects of hemin, an inducer of heme oxygenase, in a rat model of gestational hypertension and explore the possible mechanism.</p><p><b>METHODS</b>Eighteen pregnant SD rats at day 12 of gestation were randomized equally into gestational hypertension model group, hemin treatment group, and normal pregnancy (control) group. In the former two groups, the rats were subjected to daily nitro-L-arginine methyl ester (L-NAME, 80 mg/kg) gavage since gestational day 14 for 7 consecutive days to induce gestational hypertension; saline was administered in the same manner in the control rats. The rats in hemin group received daily intraperitoneal injection of hemin (30 mg/kg) starting from gestational day 16. HO activity and carboxyhemoglobin (COHb) level in rat placental tissue were detected with spectrophotometric method, and soluble vascular endothelial growth factor receptor-1 (sFlt-1) and vascular endothelial growth factor (VEGF) level in the placental tissue homogenate supernatant were detected using ELSIA.</p><p><b>RESULTS</b>At gestational day 20, the blood pressure and 24-h urinary protein were significantly higher in the model group than in the other two groups (P<0.05), and were higher in hemin group than in the control group (P<0.05); HO activity and COHb content in the placenta tissue were the lowest in the model group (P<0.05), and was lower in hemin group than in the control group (P<0.05). The level of sFlt-1 was significantly higher and VEGF level significantly lower in the model group than in the other two groups (P<0.05); sFlt-1 level remained higher and VEGF lower in hemin group than in the control group (P<0.05).</p><p><b>CONCLUSION</b>Hemin can reduce blood pressure and urinary protein in rats with gestational hypertension possibly by up-regulating HO activity, enhancing carbon monoxide production, reducing sFlt-1 and increasing VEGF in the placental tissue.</p>
Assuntos
Texto completo: 1 Base de dados: WPRIM Assunto principal: Farmacologia / Placenta / Pressão Sanguínea / Monóxido de Carbono / Ratos Sprague-Dawley / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Hipertensão Induzida pela Gravidez / Modelos Animais de Doenças / Tratamento Farmacológico Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: Zh Revista: Journal of Southern Medical University Ano de publicação: 2015 Tipo de documento: Article
Texto completo: 1 Base de dados: WPRIM Assunto principal: Farmacologia / Placenta / Pressão Sanguínea / Monóxido de Carbono / Ratos Sprague-Dawley / Receptor 1 de Fatores de Crescimento do Endotélio Vascular / Fator A de Crescimento do Endotélio Vascular / Hipertensão Induzida pela Gravidez / Modelos Animais de Doenças / Tratamento Farmacológico Tipo de estudo: Prognostic_studies Limite: Animals / Pregnancy Idioma: Zh Revista: Journal of Southern Medical University Ano de publicação: 2015 Tipo de documento: Article